This investment discipline always pays off... [Shield] AN OXFORD CLUB PUBLICATION [Liberty Through Wealth]( [View in browser]( SPONSORED [Look at What Obama Is Up to Now!]( [obamagun]( On June 14, 2023, Obama will get his last laugh. That's when a group of his hand-picked cronies may single-handedly bring this market to a sudden and destructive end. To continue reading, [click here](. EDITOR'S NOTE Last week, Alexander Green released [a special presentation on a low-priced, cancer-fighting company](. Overnight, [the stock jumped 144%](... So we rushed to record a video to update you on the situation. [You can watch it here.]( The short version of the story is... This stock still has a LOT of room to run. Here's why... Revenue is up 55% year over year... And this small stock's new drug brought in $29.5 million in sales in the first quarter. As a result, the company just beat earnings estimates by 36% and revenue estimates by 129%. [Go here to get the full story.]( - Nicole Labra, Senior Managing Editor THE SHORTEST WAY TO A RICH LIFE [The Majority of Investment Strategies Don't Work... but This One Does]( [Alexander Green | Chief Investment Strategist | The Oxford Club]( [Alexander Green]( Early in my career on Wall Street, I made an astonishing discovery: The overwhelming majority of my colleagues - though bright, educated, experienced and articulate - didn't have the foggiest idea what they were talking about. This only became obvious in retrospect, when I saw how their carefully constructed financial theories and investment forecasts turned to dust rather than generating any significant profits. (You'd be surprised to learn how many investment "pros" lose a substantial percentage of their own money in the market each year.) The truth is that there are limitless ways to take a beating in stocks - and [only a few methods that work well over time](. These few methods are codified into more widely recognized investment principles, something I try to emphasize in my Liberty Through Wealth columns. I was fortunate to realize this early in my career, although it still stings to think about the chunk of change I lost 35 years ago buying my own firm's "Strong Buy" recommendations. SPONSORED [Yours Free! Top FIVE Dividend Stocks Right Now]( Marc Lichtenfeld - income expert and author of Get Rich with Dividends - is giving away his Ultimate Dividend Package... completely free of charge! You'll discover... - An "A"-rated, ultra-safe dividend stock with a huge 8% yield
- Three of Marc's favorite "Extreme Dividend" stocks, which could supercharge your income
- And finally, Marc's No. 1 dividend stock for a LIFETIME of income. [Click here to get the names and ticker symbols now](... before the download link expires. **NO CREDIT CARD REQUIRED!** However, things finally began to turn around for me the day I read Harry Browne's - sadly out of print but with a few used copies available on Amazon - Why the Best-Laid Investment Plans Usually Go Wrong. (I loved the title, but Harry, who ran for president twice on the Libertarian ticket, told me over dinner one night that he regretted the choice. "Too negative," his publisher told him.) Browne argued that the odds are stacked against the typical investor, who is overwhelmed by market volatility, Wall Street's technical jargon and the business of money management. (Read the investment classic [Where Are the Customers' Yachts?]( for details.) There are exceptions, of course, but the nation's brokerage firms are filled with well-dressed, smart-sounding men and women spouting a lot of self-serving nonsense. As Vanguard founder John Bogle once remarked, "It's amazing how difficult it is for a man to understand something if he's paid a small fortune not to understand it." The overwhelming majority of economic theories, market forecasts, trading strategies, hot tips and surefire speculations never pan out. Fortunately, we have the accumulated wisdom of history's greatest investors to guide us. I'm talking about people like Warren Buffett, Peter Lynch and John Templeton, individuals whose audited track records speak for themselves. Even though these individuals used very different approaches, they agreed that in the end there is only one thing that dictates where a stock will go: earnings. Earnings are the net profits of a business. They are what ultimately drive share prices. I challenge you to find a single company that increased its earnings quarter after quarter, year after year, and the stock didn't tag along. Conversely, try to identify a single company whose earnings declined quarter after quarter, year after year, and the stock advanced anyway. It just doesn't happen, even in a rip-roaring bull market. The reason is simple. A share of stock is not a lottery ticket. It's part ownership of a business. And just how much investors are willing to pay for those profits will determine what a company is worth in the market. Although there are always bumps along the way, you'll find there is a near-perfect correlation between a company's growth in earnings per share and the movement of its stock from quarter to quarter and year to year. So forget all the technical mumbo-jumbo about market breadth, trading volume, put-call ratios, short interest, mutual fund inflows, advance/decline numbers and other market trivia. And instead remember that share prices follow earnings. Period. Stamp that on your forehead - act on it - and you'll be using the [one tried-and-true investment discipline]( that always pays off in the end. Despite economic turbulence and volatility in the markets, there are plenty of companies in technology, e-commerce, food, pharmaceuticals, medical devices, healthcare services, defense contracting, gold mining and other recession-resistant industries that are currently making money hand over fist. Those companies are outperforming. And they're likely to keep outperforming in the weeks and months ahead. In fact, the ingenuity of the scientists at [one tiny company with a low share price]( is lifting profits higher - and curing cancer at the same time. [I'll show you the road map to a potential fortune with this low-priced, cancer-fighting stock.]( The firm is growing sales 55% year over year... And its brand-new drug, the first of its kind for ovarian cancer, was given accelerated FDA approval in November... then sold more than $2 million worth of units in just six weeks... And there are four more drugs like it in the company's pipeline. Best of all? You can get a piece of this company for an affordable price now. [Go here for the full details.]( Good investing, Alex [Leave a Comment]( WEALTH OPPORTUNITIES - [Stock Legend Takes Down Biden Economy in Epic Video](
- [The Cost of Biden's Regulations](
- [See How to Access the Money Tool Metric Typically Reserved for World's Richest ($10M+ Net Worth)](
- [The Banks Are Not Alright]( [Panic?]( [Click here]( to watch Alex's latest video update. JOIN THE CONVERSATION [Facebook](
[Facebook](
[Twitter](
[Twitter](
[Email Share](mailto:?subject=A%20great%20piece%20from%20Liberty%20Through%20Wealth...&body=From%20Liberty%20Through%20Wealth:%0D%0A%0DThis%20investment%20discipline%20always%20pays%20off...%0A%0D
[Email Share](mailto:?subject=A%20great%20piece%20from%20Liberty%20Through%20Wealth...&body=From%20Liberty%20Through%20Wealth:%0D%0A%0DThis%20investment%20discipline%20always%20pays%20off...%0A%0D MORE FROM LIBERTY THROUGH WEALTH [Happy Money]( [You've Earned It... Now It's Time to Spend It]( [Growing Wealth]( [You've Accumulated Wealth... Now Get Ready to Use It]( [Doctor with Piggy Bank]( [Healthcare and Economic Growth Go Hand in Hand]( [Cyborg Hand]( [Why You Need Exposure to Tiny Stocks]( SPONSORED [Yours Free! Top FIVE Dividend Stocks Right Now]( Marc Lichtenfeld - income expert and author of Get Rich with Dividends - is giving away his Ultimate Dividend Package... completely free of charge! You'll discover... - An "A"-rated, ultra-safe dividend stock with a huge 8% yield
- Three of Marc's favorite "Extreme Dividend" stocks, which could supercharge your income
- And finally, Marc's No. 1 dividend stock for a LIFETIME of income. [Click here to get the names and ticker symbols now](... before the download link expires. **NO CREDIT CARD REQUIRED!** [The Oxford Club]( You are receiving this email because you subscribed to Liberty Through Wealth.
Liberty Through Wealth is published by The Oxford Club.
Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. [Privacy Policy]( | [Whitelist Liberty Through Wealth]( | [Unsubscribe]( © 2023 The Oxford Club, LLC All Rights Reserved
The Oxford Club | [105 West Monument Street](#) | [Baltimore, MD 21201](#)
North America: [1.800.589.3430](#) | International: [+1.443.353.4334](#) | Fax: [1.410.329.1923](#)
[Oxfordclub.com]( Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.